Central retinal vein occlusion post ChAdOx1 nCoV-19 vaccination – can it be explained by the two-hit hypothesis?

Abstract Purpose To report a case of central retinal vein occlusion (CRVO) seven days following the first dose of ChAdOx1 nCoV-19 vaccine and propose a hypothesis for the possible underlying pathogenesis. Observation A 31-year-old male presented with CRVO with cystoid macular edema, one week after r...

Full description

Bibliographic Details
Main Authors: Shweta Parakh, Shrey Maheshwari, Shrutanjoy Das, Hans Vaish, Gaurav Luthra, Rupesh Agrawal, Vishali Gupta, Saurabh Luthra
Format: Article
Language:English
Published: SpringerOpen 2022-10-01
Series:Journal of Ophthalmic Inflammation and Infection
Subjects:
Online Access:https://doi.org/10.1186/s12348-022-00311-4
_version_ 1797991762506022912
author Shweta Parakh
Shrey Maheshwari
Shrutanjoy Das
Hans Vaish
Gaurav Luthra
Rupesh Agrawal
Vishali Gupta
Saurabh Luthra
author_facet Shweta Parakh
Shrey Maheshwari
Shrutanjoy Das
Hans Vaish
Gaurav Luthra
Rupesh Agrawal
Vishali Gupta
Saurabh Luthra
author_sort Shweta Parakh
collection DOAJ
description Abstract Purpose To report a case of central retinal vein occlusion (CRVO) seven days following the first dose of ChAdOx1 nCoV-19 vaccine and propose a hypothesis for the possible underlying pathogenesis. Observation A 31-year-old male presented with CRVO with cystoid macular edema, one week after receiving his first ChAdOx1 nCoV-19 vaccine dose. Apart from mild hyperhomocysteinemia, no major thrombophilic or systemic risk factors were found. Anti-platelet factor 4 antibodies, specific for vaccine-induced immune thrombotic thrombocytopenia, were also negative. However, he tested strongly positive (> 250 U/mL) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG spike antibodies, 2 weeks post the first dose – suggestive of a prior subclinical infection. Conclusion COVID-19 is known to be associated with an altered host one-carbon metabolism resulting in hyperhomocysteinemia. We hypothesize that a prior subclinical infection with COVID-19, the first hit, may have led to hyperhomocysteinemia in our patient and vaccination must have been the second hit that triggered the thrombotic event. Further studies, including correlation of thrombotic complications with IgG antibody titres post-vaccination, are essential in order to better understand the pathogenesis of such events.
first_indexed 2024-04-11T08:57:26Z
format Article
id doaj.art-8f64306bae994161a0dea3537f07601f
institution Directory Open Access Journal
issn 1869-5760
language English
last_indexed 2024-04-11T08:57:26Z
publishDate 2022-10-01
publisher SpringerOpen
record_format Article
series Journal of Ophthalmic Inflammation and Infection
spelling doaj.art-8f64306bae994161a0dea3537f07601f2022-12-22T04:33:09ZengSpringerOpenJournal of Ophthalmic Inflammation and Infection1869-57602022-10-011211810.1186/s12348-022-00311-4Central retinal vein occlusion post ChAdOx1 nCoV-19 vaccination – can it be explained by the two-hit hypothesis?Shweta Parakh0Shrey Maheshwari1Shrutanjoy Das2Hans Vaish3Gaurav Luthra4Rupesh Agrawal5Vishali Gupta6Saurabh Luthra7Drishti Eye InstituteDrishti Eye InstituteDrishti Eye InstituteMeher HospitalDrishti Eye InstituteNational Healthcare Group Eye Institute, Tan Tock Seng HospitalAdvanced Eye Centre, Postgraduate Institute of Medical Education and ResearchDrishti Eye InstituteAbstract Purpose To report a case of central retinal vein occlusion (CRVO) seven days following the first dose of ChAdOx1 nCoV-19 vaccine and propose a hypothesis for the possible underlying pathogenesis. Observation A 31-year-old male presented with CRVO with cystoid macular edema, one week after receiving his first ChAdOx1 nCoV-19 vaccine dose. Apart from mild hyperhomocysteinemia, no major thrombophilic or systemic risk factors were found. Anti-platelet factor 4 antibodies, specific for vaccine-induced immune thrombotic thrombocytopenia, were also negative. However, he tested strongly positive (> 250 U/mL) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG spike antibodies, 2 weeks post the first dose – suggestive of a prior subclinical infection. Conclusion COVID-19 is known to be associated with an altered host one-carbon metabolism resulting in hyperhomocysteinemia. We hypothesize that a prior subclinical infection with COVID-19, the first hit, may have led to hyperhomocysteinemia in our patient and vaccination must have been the second hit that triggered the thrombotic event. Further studies, including correlation of thrombotic complications with IgG antibody titres post-vaccination, are essential in order to better understand the pathogenesis of such events.https://doi.org/10.1186/s12348-022-00311-4ChAdOx1 nCoV-19 vaccineCentral retinal vein occlusion (CRVO)Vaccine-induced immune thrombotic thrombocytopenia (VITT)Anti-PF4 antibodiesSARS-CoV-2Two-hit hypothesis
spellingShingle Shweta Parakh
Shrey Maheshwari
Shrutanjoy Das
Hans Vaish
Gaurav Luthra
Rupesh Agrawal
Vishali Gupta
Saurabh Luthra
Central retinal vein occlusion post ChAdOx1 nCoV-19 vaccination – can it be explained by the two-hit hypothesis?
Journal of Ophthalmic Inflammation and Infection
ChAdOx1 nCoV-19 vaccine
Central retinal vein occlusion (CRVO)
Vaccine-induced immune thrombotic thrombocytopenia (VITT)
Anti-PF4 antibodies
SARS-CoV-2
Two-hit hypothesis
title Central retinal vein occlusion post ChAdOx1 nCoV-19 vaccination – can it be explained by the two-hit hypothesis?
title_full Central retinal vein occlusion post ChAdOx1 nCoV-19 vaccination – can it be explained by the two-hit hypothesis?
title_fullStr Central retinal vein occlusion post ChAdOx1 nCoV-19 vaccination – can it be explained by the two-hit hypothesis?
title_full_unstemmed Central retinal vein occlusion post ChAdOx1 nCoV-19 vaccination – can it be explained by the two-hit hypothesis?
title_short Central retinal vein occlusion post ChAdOx1 nCoV-19 vaccination – can it be explained by the two-hit hypothesis?
title_sort central retinal vein occlusion post chadox1 ncov 19 vaccination can it be explained by the two hit hypothesis
topic ChAdOx1 nCoV-19 vaccine
Central retinal vein occlusion (CRVO)
Vaccine-induced immune thrombotic thrombocytopenia (VITT)
Anti-PF4 antibodies
SARS-CoV-2
Two-hit hypothesis
url https://doi.org/10.1186/s12348-022-00311-4
work_keys_str_mv AT shwetaparakh centralretinalveinocclusionpostchadox1ncov19vaccinationcanitbeexplainedbythetwohithypothesis
AT shreymaheshwari centralretinalveinocclusionpostchadox1ncov19vaccinationcanitbeexplainedbythetwohithypothesis
AT shrutanjoydas centralretinalveinocclusionpostchadox1ncov19vaccinationcanitbeexplainedbythetwohithypothesis
AT hansvaish centralretinalveinocclusionpostchadox1ncov19vaccinationcanitbeexplainedbythetwohithypothesis
AT gauravluthra centralretinalveinocclusionpostchadox1ncov19vaccinationcanitbeexplainedbythetwohithypothesis
AT rupeshagrawal centralretinalveinocclusionpostchadox1ncov19vaccinationcanitbeexplainedbythetwohithypothesis
AT vishaligupta centralretinalveinocclusionpostchadox1ncov19vaccinationcanitbeexplainedbythetwohithypothesis
AT saurabhluthra centralretinalveinocclusionpostchadox1ncov19vaccinationcanitbeexplainedbythetwohithypothesis